Contract Research Organization (CROs) Services Market Size, Share Report, 2026-2034
REPORT DETAILS
Contract Research Organization (CRO) Services Market Size & Forecast, 2025–2034
Contract research organization (CROs) services market size was valued at USD 75.32 billion in 2025. The market is anticipated to grow from USD 80.85 billion in 2026 to USD 143.41 billion by 2034, exhibiting the CAGR of 7.42% during the forecast period
Market Statistics
CRO Services Market Key Takeaways: Size, Share, Segments & Regions
- North America held the largest market share of nearly 42.30% in 2025. The region is expected to grow at a steady pace owing to the presence of significant research activities and clinical trials.
- Asia Pacific is projected to grow at a CAGR of around 9.80% during the forecast period. The region is observing an increase in outsourcing research work by pharmaceutical and biotechnology companies.
- Clinical research services held the largest service type share in 2025, accounting for approximately 46.70%. More drug companies outsourced clinical trials to improve development efficiency.
- Oncology held the largest therapeutic area share in 2025, contributing nearly 31.80% of revenue. Growing cancer incidence and increasing oncology clinical trials drove research activity.
- Pharmaceutical and biopharmaceutical companies held the largest end-use share in 2025, accounting for approximately 58.90%. The trend of outsourcing drug development activities continued to accelerate.
- Laboratory services are projected to grow at a CAGR of around 10.40% during the forecast period (2026–2034), driven by rising demand for specialized testing and analytical services.
Note: Figures and projections outlined in this report are the result of Polaris Market Research’s proprietary analytical processes, grounded in the latest available datasets and market observations.
What are contract research organization (CRO) services?
The contract research organization (CRO) services market comprises companies that provide outsourced research services to pharmaceutical, biotechnology, and medical device companies. These services include drug discovery, preclinical studies, clinical trials, laboratory testing, regulatory support, and other services that facilitate the development and commercialization of new healthcare products.
CRO Services Market Dynamics: Drivers, Opportunities, Restraints & Challenges
- Rising chronic diseases are increasing the need for new treatments. This is driving demand for CRO services.
- More clinical trials are boosting the need for outsourced research. This is still aiding market growth.
- Pharmaceutical and medical device companies are outsourcing research to reduce costs. This is increasing demand for CRO services.
- Increasing R&D expenditure is leading to more research projects. This is aiding market growth.
- Strict regulations and shortage of skilled professionals may delay projects. These are still major market challenges.
-services-market-size-by-region-2021-2034.png)
Source: Polaris Market Research Analysis
To Understand More About this Research: Download Sample Report
CRO Services Market Drivers
Rising Clinical Trial Volume and Complexity Are Increasing CRO Outsourcing
The increase in chronic diseases is anticipated to drive the growth of the contract research organization market demand in the market forecast period. Sedentary lifestyles, poor dietary choices, tobacco use, and smoking are major contributors to the rise in chronic diseases. Furthermore, the emergence of the COVID-19 pandemic has resulted in a global focus on research and development, contributing to increased spending in this sector.
The rising number of patients suffering from chronic diseases is expected to drive the growth of the contract research organization market. According to World Health Organization (WHO) data, a significant portion of the population suffers from chronic illnesses. Every year, approximately 41 million people die from chronic diseases. To reduce costs and workload, companies that manufacture pharmaceuticals and medical devices for chronic disease treatments are gradually outsourcing their early-phase clinical trials. This outsourcing trend is anticipated to drive the growth of the contract research organization services market development.
Market Restraints
Stringent regulatory challenges and lack of skilled professionals hamper on the growth of the market
The contract research organization operates under strict regulatory guidelines from bodies such as the FDA and EMA. These guidelines establish stringent compliance standards, including extensive documentation, stringent quality control measures, and a commitment to ethical behavior. Complying with these standards can be complex and resource-intensive, resulting in additional costs, time-consuming processes, and potential project delays. The need for strict adherence adds complexity to contract research operations, affecting their effectiveness and financial performance.
The contract research organization market growth faces a challenge due to a need for more skilled professionals, which has impacts across multiple domains, including Therapeutic Expertise, and weakens the effectiveness of Patient Recruitment. This shortage has implications for regulatory affairs, which pose challenges for services such as clinical data analysis and clinical custom synthesis.
How CRO Services Work Across Drug Discovery and Clinical Development
Contract research organizations, or CROs, help pharmaceutical, biotechnology and medical device companies with the various stages of drug development. CROs design preclinical studies and clinical trials. They enroll research participants and monitor research sites. They make sure studies adhere to regulatory and ethical standards.
CROs collect and analyze clinical data. They prepare study reports and regulatory documents. They collaborate with sponsors throughout the research life cycle. Their services help to reduce development time and increase efficiency. The end results support regulatory approval and commercialization of products.
The increasing investment in the R&D programs, preference for the outsourcing activities owing to time and cost constraints, and the patent expiration of blockbuster drugs are the crucial factors that are anticipated to drive the growth of the market in the forecast period. Contract research outsourcing partnerships provide a sophisticated level of service, prompting biopharmaceutical and pharmaceutical companies to entrust most projects to contract research organizations. This is facilitating the growth of the market.
- For instance, in October 2023, according to the Australian Government Department of Health and Aged Care, the Clinical Trials Activity initiative will receive $750 million over ten years, starting in the year 2022-23.
Contract Research Organizations (CROs) rely on their specialized expertise and regulatory knowledge to effectively manage complicated clinical trials in the pharmaceutical, biotechnology, and medical device industries. Contract Research Organizations offer a broad range of services, including data management, patient recruitment, study design, and regulatory compliance, significantly driving market growth.
A Contract Research Organization is a company that provides research services to the biotechnology, medical device, and pharmaceutical industries on a contract basis. The services offered include biologic assay development, biopharmaceutical development, preclinical research, commercialization, clinical trial management, clinical research, and pharmacology. A contract research organization, also known as a Clinical Research Organization, an outsourcing partner for pharmaceutical and biotechnology companies that cater to research needs for medical and drug devices.
The complex processes involved in drug development facilitates the growth of the market. Contract research organizations offer specialized expertise and capabilities in genomics, pharmacovigilance, data analytics, and regulatory affairs. Numerous CROs actively collaborate with pharmaceutical companies on research and innovation, resulting in the development of novel methodologies, technologies, and therapies. Furthermore, contract research organizations allow pharmaceutical companies to focus on their core competencies, such as drug discovery, marketing, and market access, by outsourcing specific research tasks.
Electronic data capture (EDC), electronic trial master files, and risk-based monitoring have changed the way of research processes. Contract research organizations (CROs) have positioned themselves at the forefront by enthusiastically embracing and leveraging these advanced technologies, allowing them to offer exceptional advantages to their clients. Furthermore, the use of risk-based monitoring methods enables CROs to identify and manage potential risks as they arise, ensuring the quality and compliance of studies in real-time.
The COVID-19 pandemic has had a positive and negative impact on the contract research organization services market. The growth of the market was slowed in 2020 owing to the lockdown. During the COVID-19 pandemic, numerous pharmaceutical and biopharmaceutical companies increased their efforts in R&D and manufacturing procedures to develop and distribute testing kits, vaccines, and medications that target the SARS-CoV-2 virus. To strengthen their R&D initiatives, these pharmaceutical and biotech companies formed extensive collaborations with Contract Research Organizations (CROs) through global, long-term agreements, partnerships, and cooperative ventures.
- For instance, In January 2021, ICON formed a partnership with Pfizer and BioNTech to launch a ground-breaking initiative aimed at developing experimental COVID-19 vaccines.
The COVID-19 pandemic has hampered the growth of the contract research organization services market. The suspension of clinical trial activities has reduced demand for contract research organization services. Furthermore, government-imposed measures such as travel restrictions, lockdowns, and social distancing have had a negative impact on the growth of the contract research organization services market.
In-House R&D vs. CRO Outsourcing: Cost, Expertise, Control & Timelines
| Parameter | In-House Research | CRO Outsourcing |
| Research Cost | Managed by the company's own team | Managed by an external CRO |
| Cost | Higher research costs | Lower research costs |
| Expertise | Uses in-house expertise | Access to specialized expertise |
| Resources | Limited to internal resources | Flexible research resources |
| Timeline | May take more time | Often completed faster |
| Main Benefit | More control over the process | Better flexibility and efficiency |
Source: Polaris Market Research Analysis
AI, Digital Recruitment and Patient Engagement in CRO-Led Clinical Trials
Contract research organizations (CROs) are employing online platforms, artificial intelligence tools and remote monitoring to improve clinical trials. These tools help you find the right patients in lesser time. They also help you stay in touch with participants throughout the study. Constant follow-ups keep patients involved until the end of the trial. This supports to prevent dropouts and delays. Clinical trials proceed more smoothly and research can be completed more quickly.
Role of CROs Across Drug Discovery, Clinical Development and Regulatory Approval
Contract research organizations are involved in all phases of drug development. They help in discovery research, preclinical studies and clinical trials. They also help in preparing documents for regulatory approval. Once approval is obtained CROs provide post-market monitoring and other research services. They also help product launch and commercialization. Their services help companies bring new medicines and medical products to the market faster.
-services-market-trends-&-key-players-2021-2034.png)
Source: Polaris Market Research Analysis
CRO Services Market Segmentation
The market is primarily segmented based on service type, therapeutic area, end-use, and region.
| By Service Type | By Therapeutic Area | By End-Use | By Region |
|
|
|
|
Source: Polaris Market Research Analysis
CRO Services Market by Service Type: Clinical, Early-Phase, Laboratory & Consulting
- The clinical research services segment held the largest market share in 2025. The increasing prevalence of individuals with chronic illnesses is driving a heightened demand for additional clinical trial endeavors, significantly contributing to the expansion of this sector. Furthermore, the rising inclination among pharmaceutical and biotechnology firms to delegate their clinical trial operations is expected to drive the growth of the contract research organization services market segment.
CRO Services Market by Therapeutic Area: Oncology, CNS, Cardiology & More
- The oncology segment accounted for the largest market revenue share in 2025. The rise in cancer incidence and the growing demand for novel cancer treatments are contract research organization services market drivers for the growth of the segment. For instance, in 2020, the World Cancer Research Fund (WCRF) reported 18.1 million new cancer cases. Furthermore, the growing trend toward personalized medicine in oncology, combined with increased interest from pharmaceutical and biotechnology companies in outsourcing clinical trial activities for comprehensive oncology research to advance new treatments, is anticipated to drive the growth of the segment.
CRO Services Market by End User: Pharma, Biotech, Medical Devices & Research Institutes
- Based on end-use analysis, the market has been segmented on the basis of pharmaceuticals and biopharmaceuticals, medical device companies, academic and research institutes, and others. The pharmaceuticals and biopharmaceuticals segment held the largest revenue share in the market. The growing trend of pharmaceutical and biotech companies, particularly smaller and mid-sized enterprises needing more expertise in the preclinical phase of drug development, to outsource comprehensive services is anticipated to drive demand for this segment during the contract research organization services market forecast period. This growth is mainly driven by expanding biotechnology product pipelines and a shift in the trend of biotech companies retaining their assets for longer periods.
Common CRO Service Use Cases Across Drug, Biologic and Medical Device Development
| Application | Description |
| Clinical Trial Management | Manages clinical trials for new drugs and therapies |
| Vaccine and Biologics Development | Supports research and testing of vaccines and biologics |
| Oncology and Rare Disease Research | Conducts studies for cancer and rare diseases |
| Medical Device Testing | Tests and validates medical devices before approval |
| Pharmacovigilance | Monitors drug safety and reports side effects |
| Regulatory Support | Helps prepare documents and meet regulatory requirements |
Source: Polaris Market Research Analysis
-services-market-by-product-analysis-2021-2034.png)
Source: Polaris Market Research Analysis
CRO Services Market Regional Analysis: North America, Europe, Asia Pacific, Latin America & MEA
North America Led the CRO Services Market with ~42.3% Share in 2025
- North America dominated the contract research organization services market due to the presence of numerous contract research organizations, which are equipped with advanced technologies and systems to equalize the entire processes delivered by the companies. The contract research organization market in North America is anticipated to expand due to an increased demand for cutting-edge technologies in disease diagnosis and treatment. Increased investment in R&D by regional companies, research institutes, and non-profit organizations has accelerated market growth. Furthermore, the rising prevalence of chronic diseases, a growing demand for low-cost digital health solutions, and a geriatric population have contributed to increased R&D activity.
Asia Pacific CRO Services Market to Grow Fastest at ~9.8% CAGR
- Asia Pacific has witnessed the fastest growth in the market, owing to the increasing number of pharmaceutical and biotechnology companies, as clinical trials are conducted in more numbers in the region. Also, the region has a large population, which is an essential factor in the contract research organization services market is responsible for growth of this segment.
-services-market-trends-by-region-2021–2034.png)
Source: Polaris Market Research Analysis
Key CRO Services Market Challenges: Regulation, Patient Retention, Cybersecurity & Talent
The contract research organization (CRO) services market faces several challenges. Different countries have different regulatory requirements. This makes global clinical studies more complex and time-consuming. Advanced clinical trials also require high investment. Finding suitable patients and keeping them in trials can be difficult. CROs also need to protect large volumes of clinical data from security risks. Data privacy remains an important concern. Furthermore, there is a shortage of skilled professionals in specialized research fields. Such challenges may lead to increasing costs, delays in research activities and an overall slower drug development process.
CRO Services Market Competitive Landscape & Leading Companies
The market is characterized by intense competition, with established players relying on advanced technology, high-quality products, and a strong brand image to drive revenue growth. These companies employ various strategies such as research and development, mergers and acquisitions, and technological innovations to expand their product portfolios and maintain a competitive edge in the market.
Leading Contract Research Organizations (CROs) in the Global Market
- AccuLab Life Sciences
- Caidya
- Charles River Laboratories
- CTI Clinical Trial & Consulting
- IQVIA Inc.
- KCR S.A.
- Labcorp Drug Development
- Lexitas
- Medpace
- Parexel International (MA) Corporation
- Pharmaron
- Syneos Health
- TFS HealthScience
- Thermo Fisher Scientific Inc.
Future Outlook for the Contract Research Organization (CRO) Services Market
The contract research organization (CRO) services market is expected to see steady growth over the coming years. More pharmaceutical, biotechnology, and medical device companies are expected to outsource research activities to reduce costs and speed up drug development. The use of AI, digital technologies, and decentralized clinical trials are also expected to grow. The demand for biologics, precision medicine and advanced therapies will create new opportunities for CROs. Companies will continue to focus on faster and more efficient clinical research. As research needs grow globally, CROs are expected to play a larger role in bringing new medicines and healthcare products to market.
Recent CRO Mergers, Acquisitions, Partnerships & Capacity Expansions, 2025–2026
- May 2026: Thermo Fisher Scientific's PPD Clinical Research business opened a new bioanalytical laboratory in Gothenburg, Sweden. The facility expands its laboratory network. It will support global clinical development programs. It also strengthens bioanalytical testing services.(Source: www.ppd.com)
- February 2026: IQVIA has signed an agreement to acquire selected drug discovery assets from Charles River Laboratories. The deal expands its early-stage drug discovery services. It also adds AI-based research capabilities. This strengthens IQVIA’s research portfolio.(Source: www.iqvia.com)
CRO Services Market Report Coverage & Research Scope
The Contract Research Organization (CROs) Services Market report emphasizes key regions across the globe to provide a better understanding of the product to the users. Also, the report provides market insights into recent developments and trends and analyzes the technologies that are gaining traction around the globe. Furthermore, the report covers an in-depth qualitative analysis pertaining to various paradigm shifts associated with the transformation of these solutions.
The report provides a detailed analysis of the market while focusing on various key aspects such as competitive analysis, service type, therapeutic area, end-use, and futuristic growth opportunities.
Contract Research Organization (CROs) Services Market Report Scope
| Report Attributes | Details |
| Market size value in 2025 | USD 75.32 billion |
| Market size value in 2026 | USD 80.85 billion |
| Revenue forecast in 2034 | USD 143.41 billion |
| CAGR | 7.42% from 2026 – 2034 |
| Base year | 2025 |
| Historical data | 2021 – 2024 |
| Forecast period | 2026 – 2034 |
| Quantitative units | Revenue in USD billion and CAGR from 2026 to 2034 |
| Segments Covered | By Service Type, By Therapeutic Area, By End-Use, By Region |
| Regional scope | North America, Europe, Asia Pacific, Latin America; Middle East & Africa |
| Customization | Report customization as per your requirements with respect to countries, region and segmentation |
Source: Polaris Market Research Analysis
Quality Assured
We strive to offer our clients the finest in market research with the most reliable and accurate research findings. We use industry-standard methodologies to offer a comprehensive and authentic analysis of the Contract Research Organization (CROs) Services Market. Besides, we have stringent data-quality checks in place to enable data-driven decision-making for you.
Browse Our Top Selling Reports
Abrasive Blasting Nozzle Market Size, Share 2024 Research Report
Camping Coolers Market Size, Share 2024 Research Report
Clinical Communication and Collaboration Market Size, Share 2024 Research Report
Coin Operated Laundries Market Size, Share 2024 Research Report
Plastics in Electrical and Electronics Market Size, Share 2024 Research Report
Contract Research Organization (CROs) Services Market FAQ's
AccuLab Life Sciences, Caidya, Charles River Laboratories, CTI Clinical Trial & Consulting, IQVIA Inc., KCR S.A are the key companies in Contract Research Organization (CROs) Services Market.
Contract research organization (CROs) services market is CAGR of 7.42% during the forecast period
The Contract Research Organization (CROs) Services Market report covering key segments are service type, therapeutic area, end-use, and region.
Increasing technological advancements will facilitate the growth of the market. are the key driving factors in Contract Research Organization (CROs) Services Market
The Contract Research Organization (CROs) Services market size is expected to reach USD 143.41 Billion by 2034
Download Sample Report of Contract Research Organization (CROs) Services Market
Please fill out the form to request a customized copy of the research report.
